Kirr Marbach & Co. LLC IN Has $3.61 Million Position in Rxo Inc (NYSE:RXO)

Kirr Marbach & Co. LLC IN grew its stake in shares of Rxo Inc (NYSE:RXOFree Report) by 1.1% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 188,826 shares of the company’s stock after buying an additional 2,049 shares during the period. Kirr Marbach & Co. LLC IN’s holdings in RXO were worth $3,607,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in the stock. Oppenheimer & Co. Inc. raised its position in shares of RXO by 24.4% during the first quarter. Oppenheimer & Co. Inc. now owns 37,440 shares of the company’s stock valued at $715,000 after buying an additional 7,343 shares during the last quarter. Oppenheimer Asset Management Inc. raised its position in shares of RXO by 21.6% during the first quarter. Oppenheimer Asset Management Inc. now owns 45,536 shares of the company’s stock valued at $870,000 after buying an additional 8,080 shares during the last quarter. Vaughan Nelson Investment Management L.P. raised its position in shares of RXO by 15.0% during the first quarter. Vaughan Nelson Investment Management L.P. now owns 2,730,665 shares of the company’s stock valued at $52,155,000 after buying an additional 355,255 shares during the last quarter. SG Americas Securities LLC raised its position in shares of RXO by 251.2% during the first quarter. SG Americas Securities LLC now owns 51,761 shares of the company’s stock valued at $989,000 after buying an additional 37,024 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. raised its position in RXO by 52.5% in the first quarter. Thurston Springer Miller Herd & Titak Inc. now owns 2,745 shares of the company’s stock worth $52,000 after purchasing an additional 945 shares in the last quarter. Institutional investors and hedge funds own 92.73% of the company’s stock.

RXO Stock Performance

NYSE RXO opened at $15.84 on Tuesday. The firm has a market cap of $2.60 billion, a price-to-earnings ratio of -7.30, a PEG ratio of 6.39 and a beta of 1.73. The company has a 50 day moving average of $15.04 and a 200-day moving average of $19.43. The company has a current ratio of 1.30, a quick ratio of 1.30 and a debt-to-equity ratio of 0.24. Rxo Inc has a 1-year low of $12.19 and a 1-year high of $32.82.

RXO (NYSE:RXOGet Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.01). RXO had a negative net margin of 5.94% and a positive return on equity of 1.18%. The company had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.51 billion. During the same period last year, the company earned ($0.03) earnings per share. RXO’s revenue for the quarter was up 57.0% compared to the same quarter last year. On average, equities analysts forecast that Rxo Inc will post 0.31 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. The Goldman Sachs Group dropped their price target on shares of RXO from $21.00 to $18.00 and set a “neutral” rating for the company in a research report on Thursday, May 8th. Barclays dropped their price target on shares of RXO from $24.00 to $22.00 and set an “overweight” rating for the company in a research report on Wednesday, April 2nd. Wells Fargo & Company dropped their price target on shares of RXO from $20.00 to $15.00 and set an “equal weight” rating for the company in a research report on Thursday, May 8th. Stifel Nicolaus dropped their price target on shares of RXO from $24.00 to $14.00 and set a “hold” rating for the company in a research report on Thursday, May 8th. Finally, Jefferies Financial Group dropped their price target on shares of RXO from $26.00 to $20.00 and set a “buy” rating for the company in a research report on Friday, April 11th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $20.00.

Read Our Latest Stock Analysis on RXO

RXO Profile

(Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Featured Stories

Want to see what other hedge funds are holding RXO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rxo Inc (NYSE:RXOFree Report).

Institutional Ownership by Quarter for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.